Nuvation Bio (NUVB) News Today $2.46 +0.19 (+8.37%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$2.48 +0.02 (+0.61%) As of 05/2/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period XTX Topco Ltd Has $28,000 Holdings in Nuvation Bio Inc. (NYSE:NUVB)XTX Topco Ltd decreased its position in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 92.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,585 shares of the company's stock after selling 121,444 sMay 4 at 3:36 AM | marketbeat.comNuvation Bio (NUVB) Expected to Announce Earnings on WednesdayNuvation Bio (NYSE:NUVB) will be releasing its Q1 2025 earnings after the market closes on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-nuvation-bio-inc-stock/)May 2 at 9:12 AM | marketbeat.comNuvation Bio to Present at The Citizens Life Sciences ConferenceMay 1 at 4:05 PM | businesswire.comRenaissance Technologies LLC Has $1.51 Million Stake in Nuvation Bio Inc. (NYSE:NUVB)Renaissance Technologies LLC trimmed its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 44.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 566,800 shares of the company's stock after sellApril 30, 2025 | marketbeat.comBrokerages Set Nuvation Bio Inc. (NYSE:NUVB) Price Target at $7.83April 26, 2025 | americanbankingnews.comNuvation Bio (NYSE:NUVB) Earns Market Outperform Rating from Analysts at JMP SecuritiesJMP Securities initiated coverage on shares of Nuvation Bio in a research report on Wednesday. They issued a "market outperform" rating and a $6.00 price objective on the stock.April 25, 2025 | marketbeat.comNuvation Bio initiated with an Outperform at Citizens JMPApril 24, 2025 | markets.businessinsider.comJMP Securities Initiates Coverage of Nuvation Bio (NUVB) with Market Outperform RecommendationApril 23, 2025 | msn.comGeode Capital Management LLC Raises Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB)Geode Capital Management LLC raised its holdings in shares of Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 22.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,951,195 shares of the compaApril 23, 2025 | marketbeat.comNuvation Bio to Report Results for First Quarter 2025 and Provide Business Update on May 7, 2025April 22, 2025 | businesswire.comFederated Hermes Inc. Sells 349,503 Shares of Nuvation Bio Inc. (NYSE:NUVB)Federated Hermes Inc. lowered its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 95.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,439 shares of the company's stock after selApril 21, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Down 6.4% - Should You Sell?Nuvation Bio (NYSE:NUVB) Stock Price Down 6.4% - Here's WhyApril 18, 2025 | marketbeat.comIs Nuvation Bio Inc. (NYSE:NUVB) the Best Biotech Penny Stock to Buy According to Hedge Funds?April 16, 2025 | insidermonkey.comNuvation Bio Inc. (NYSE:NUVB) Shares Acquired by Fmr LLCFmr LLC lifted its position in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 54.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 45,285,572 shares of the company's stock after acquiring an additional 16,April 16, 2025 | marketbeat.comIs Nuvation Bio Inc. (NUVB) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?April 14, 2025 | msn.comNuvation Bio Inc. (NYSE:NUVB) Shares Acquired by Vanguard Group Inc.Vanguard Group Inc. increased its stake in shares of Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 45.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,732,567 shares of the company's stock after buApril 14, 2025 | marketbeat.comInsider Buying: Nuvation Bio Inc. (NYSE:NUVB) CEO Purchases 200,000 Shares of StockNuvation Bio Inc. (NYSE:NUVB - Get Free Report) CEO David Hung acquired 200,000 shares of Nuvation Bio stock in a transaction on Friday, April 4th. The shares were bought at an average cost of $1.66 per share, with a total value of $332,000.00. Following the completion of the transaction, the chief executive officer now owns 58,481,054 shares of the company's stock, valued at approximately $97,078,549.64. This trade represents a 0.34 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.April 11, 2025 | marketbeat.comDavid Hung Acquires 300,000 Shares of Nuvation Bio Inc. (NYSE:NUVB) StockNuvation Bio Inc. (NYSE:NUVB - Get Free Report) CEO David Hung bought 300,000 shares of the stock in a transaction that occurred on Monday, April 7th. The shares were bought at an average cost of $1.62 per share, with a total value of $486,000.00. Following the completion of the transaction, the chief executive officer now owns 58,781,054 shares in the company, valued at $95,225,307.48. The trade was a 0.51 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.April 10, 2025 | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) CEO David Hung Acquires 200,000 SharesApril 10, 2025 | insidertrades.comTuesday’s Insider Activity: Key Buys and Sells in US StocksApril 9, 2025 | investing.comNuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will TripleApril 9, 2025 | msn.comNuvation Bio (NYSE:NUVB) Reaches New 1-Year Low - What's Next?Nuvation Bio (NYSE:NUVB) Sets New 52-Week Low - Here's WhyApril 9, 2025 | marketbeat.comDavid Hung Buys 300,000 Shares of Nuvation Bio Inc. (NYSE:NUVB) StockApril 9, 2025 | insidertrades.comNuvation Bio (NYSE:NUVB) Stock Price Up 5.4% - Here's What HappenedNuvation Bio (NYSE:NUVB) Trading Up 5.4% - Here's What HappenedApril 4, 2025 | marketbeat.comNuvation Bio to Present at the Jones Healthcare and Technology Innovation ConferenceApril 2, 2025 | businesswire.comNuvation Bio (NYSE:NUVB) Sets New 12-Month Low - Should You Sell?Nuvation Bio (NYSE:NUVB) Reaches New 12-Month Low - Here's What HappenedApril 1, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Receives "Outperform" Rating from WedbushWedbush restated an "outperform" rating and set a $5.00 price objective on shares of Nuvation Bio in a research report on Thursday.March 28, 2025 | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) Stock Position Boosted by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. grew its stake in shares of Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 39.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,945,983 shares of the company'sMarch 26, 2025 | marketbeat.comInsider Stock Buying Reaches US$720.1k On Nuvation BioMarch 25, 2025 | uk.finance.yahoo.comNuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025March 25, 2025 | businesswire.comStock Traders Buy High Volume of Nuvation Bio Put Options (NYSE:NUVB)Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) saw some unusual options trading activity on Thursday. Traders acquired 7,110 put options on the company. This is an increase of 7,800% compared to the typical volume of 90 put options.March 21, 2025 | marketbeat.comIs Nuvation Bio Inc. (NYSE:NUVB) the Most Oversold Penny Stocks to Buy According to Analysts?March 17, 2025 | msn.comNuvation Bio (NYSE:NUVB) Shares Down 2.5% - Time to Sell?Nuvation Bio (NYSE:NUVB) Shares Down 2.5% - What's Next?March 15, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Upgraded to "Strong-Buy" at Jones TradingJones Trading upgraded Nuvation Bio to a "strong-buy" rating in a research note on Tuesday.March 15, 2025 | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) Receives Consensus Recommendation of "Buy" from AnalystsShares of Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) have been assigned an average recommendation of "Buy" from the six research firms that are presently covering the firm, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average twelve-month target priceMarch 13, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Coverage Initiated by Analysts at Jones TradingJones Trading started coverage on Nuvation Bio in a research report on Wednesday. They issued a "buy" rating and a $10.00 price objective for the company.March 13, 2025 | marketbeat.comJones Trading Initiates Coverage of Nuvation Bio (NUVB) with Buy RecommendationMarch 12, 2025 | msn.comQ1 EPS Estimates for Nuvation Bio Lowered by HC WainwrightNuvation Bio Inc. (NYSE:NUVB - Free Report) - Research analysts at HC Wainwright cut their Q1 2025 earnings estimates for Nuvation Bio in a research report issued to clients and investors on Monday, March 10th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings ofMarch 12, 2025 | marketbeat.comNuvation Bio initiated with a Buy at JonesResearchMarch 11, 2025 | markets.businessinsider.comNuvation Bio price target lowered to $10 from $11 at H.C. WainwrightMarch 10, 2025 | markets.businessinsider.comNuvation Bio (NYSE:NUVB) Shares Gap Down After Analyst DowngradeNuvation Bio (NYSE:NUVB) Shares Gap Down Following Analyst DowngradeMarch 10, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Given New $10.00 Price Target at HC WainwrightHC Wainwright lowered their target price on Nuvation Bio from $11.00 to $10.00 and set a "buy" rating for the company in a research note on Monday.March 10, 2025 | marketbeat.comQ1 Earnings Estimate for Nuvation Bio Issued By WedbushNuvation Bio Inc. (NYSE:NUVB - Free Report) - Equities researchers at Wedbush issued their Q1 2026 earnings per share estimates for Nuvation Bio in a report released on Thursday, March 6th. Wedbush analyst D. Nierengarten anticipates that the company will earn ($0.23) per share for the quarter. WMarch 10, 2025 | marketbeat.comNuvation Bio Inc. (NUVB): Among the Best NYSE Penny Stocks to Buy According to AnalystsMarch 9, 2025 | insidermonkey.comNuvation Bio (NYSE:NUVB) Stock Price Up 8% - Still a Buy?Nuvation Bio (NYSE:NUVB) Trading Up 8% - Here's What HappenedMarch 8, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Releases Earnings Results, Misses Estimates By $0.01 EPSNuvation Bio (NYSE:NUVB - Get Free Report) issued its earnings results on Thursday. The company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.01).March 7, 2025 | marketbeat.comNuvation Bio files automatic mixed securities shelfMarch 7, 2025 | markets.businessinsider.comWedbush Has Pessimistic View of Nuvation Bio Q3 EarningsNuvation Bio Inc. (NYSE:NUVB - Free Report) - Analysts at Wedbush dropped their Q3 2025 EPS estimates for Nuvation Bio in a research report issued on Monday, March 3rd. Wedbush analyst D. Nierengarten now expects that the company will post earnings of ($0.17) per share for the quarter, down fromMarch 7, 2025 | marketbeat.comNuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 6, 2025 | businesswire.comNuvation Bio (NYSE:NUVB) Given "Outperform" Rating at WedbushWedbush reiterated an "outperform" rating and set a $5.00 price objective on shares of Nuvation Bio in a research report on Monday.March 4, 2025 | marketbeat.com Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address NUVB Media Mentions By Week NUVB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUVB News Sentiment▼0.830.58▲Average Medical News Sentiment NUVB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUVB Articles This Week▼33▲NUVB Articles Average Week Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Viking Therapeutics News Xenon Pharmaceuticals News Catalyst Pharmaceuticals News MorphoSys News Protagonist Therapeutics News HUTCHMED News Immunovant News MoonLake Immunotherapeutics News ACADIA Pharmaceuticals News Alvotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NUVB) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvation Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NUVB Stock Free NUVB Stock Alerts